Success Metrics

Clinical Success Rate
100.0%

Based on 1 completed trials

Completion Rate
100%(1/1)
Active Trials
0(0%)
Results Posted
0%(0 trials)

Phase Distribution

Ph not_applicable
2
50%

Phase Distribution

0

Early Stage

0

Mid Stage

0

Late Stage

Phase Distribution2 total trials
N/ANon-phased studies
2(100.0%)

Highest Phase Reached

Unknown

Trial Status & Enrollment

Completion Rate

100.0%

1 of 1 finished

Non-Completion Rate

0.0%

0 ended early

Currently Active

0

trials recruiting

Total Trials

4

all time

Status Distribution
Completed(1)
Other(3)

Detailed Status

unknown3
Completed1

Development Timeline

Analytics

Development Status

Total Trials
4
Active
0
Success Rate
100.0%
Most Advanced
N/A

Trials by Phase

N/A2 (100.0%)

Trials by Status

unknown375%
completed125%

Recent Activity

0 active trials
Showing 4 of 4
completed

Multiple Sclerosis: The Role of Mitochondrial Dysfunction in IR Resistance

NCT03052595
unknown

Neuroinflammation and Alzheimer's Pathology in POCD

NCT05378659
unknownnot_applicable

Interaction of the Cognitive and Sensory-cognitive Tasks With Postural Stability in Individuals With Stability Disorders

NCT05024240
unknownnot_applicable

The Role of the FTO Gene in Reward System Activation in Obese and Healthy Subjects

NCT01863212

Clinical Trials (4)

Showing 4 of 4 trials
NCT03052595

Multiple Sclerosis: The Role of Mitochondrial Dysfunction in IR Resistance

Completed
NCT05378659

Neuroinflammation and Alzheimer's Pathology in POCD

Unknown
NCT05024240Not Applicable

Interaction of the Cognitive and Sensory-cognitive Tasks With Postural Stability in Individuals With Stability Disorders

Unknown
NCT01863212Not Applicable

The Role of the FTO Gene in Reward System Activation in Obese and Healthy Subjects

Unknown

All 4 trials loaded

Drug Details

Intervention Type
DIAGNOSTIC TEST
Total Trials
4